Headlines about K2M Group Holdings (NASDAQ:KTWO) have trended somewhat positive this week, according to Accern Sentiment. The research firm identifies positive and negative press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. K2M Group Holdings earned a media sentiment score of 0.12 on Accern’s scale. Accern also assigned news articles about the medical device company an impact score of 46.0660732617946 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Shares of K2M Group Holdings (NASDAQ KTWO) traded down 7.02% during mid-day trading on Friday, hitting $20.66. 1,363,420 shares of the stock traded hands. The firm’s 50 day moving average price is $23.15 and its 200 day moving average price is $22.35. K2M Group Holdings has a 12-month low of $16.32 and a 12-month high of $25.99. The firm’s market cap is $893.92 million.

K2M Group Holdings (NASDAQ:KTWO) last announced its quarterly earnings results on Tuesday, August 1st. The medical device company reported ($0.21) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.22) by $0.01. The business had revenue of $65.70 million during the quarter, compared to the consensus estimate of $66.26 million. K2M Group Holdings had a negative net margin of 16.21% and a negative return on equity of 15.45%. The business’s revenue was up 11.0% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.27) EPS. On average, equities research analysts predict that K2M Group Holdings will post ($0.78) EPS for the current fiscal year.

Several analysts have recently issued reports on KTWO shares. Zacks Investment Research upgraded shares of K2M Group Holdings from a “sell” rating to a “hold” rating in a research report on Saturday, August 5th. JMP Securities reiterated an “outperform” rating and issued a $30.00 target price (up previously from $27.00) on shares of K2M Group Holdings in a research report on Wednesday, June 28th. BidaskClub upgraded shares of K2M Group Holdings from a “hold” rating to a “buy” rating in a research report on Wednesday, July 19th. Needham & Company LLC reiterated a “buy” rating on shares of K2M Group Holdings in a research report on Wednesday, August 2nd. Finally, Oppenheimer Holdings, Inc. set a $29.00 target price on shares of K2M Group Holdings and gave the company a “buy” rating in a research report on Wednesday, August 2nd. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. K2M Group Holdings has an average rating of “Buy” and a consensus price target of $27.14.

TRADEMARK VIOLATION NOTICE: This news story was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this news story can be read at https://www.thecerbatgem.com/2017/09/17/k2m-group-holdings-ktwo-given-daily-coverage-optimism-score-of-0-12.html.

In related news, CFO Gregory S. Cole sold 2,350 shares of the stock in a transaction dated Tuesday, August 15th. The shares were sold at an average price of $24.08, for a total value of $56,588.00. Following the sale, the chief financial officer now directly owns 55,158 shares of the company’s stock, valued at approximately $1,328,204.64. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider John Philip Md Kostuik sold 1,090 shares of the stock in a transaction dated Tuesday, August 15th. The shares were sold at an average price of $24.08, for a total transaction of $26,247.20. Following the completion of the sale, the insider now directly owns 201,961 shares in the company, valued at $4,863,220.88. The disclosure for this sale can be found here. Over the last three months, insiders sold 45,085 shares of company stock worth $1,056,903. 5.80% of the stock is owned by corporate insiders.

K2M Group Holdings Company Profile

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Insider Buying and Selling by Quarter for K2M Group Holdings (NASDAQ:KTWO)

Receive News & Stock Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related stocks with our FREE daily email newsletter.